13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00228228 (ClinicalTrials.gov) | May 2002 | 26/9/2005 | TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis | T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis | Multiple Sclerosis | Biological: T cell vaccination | Sheba Medical Center | NULL | Recruiting | 15 Years | 50 Years | Both | 80 | Phase 3 | Israel |
2 | NCT00220428 (ClinicalTrials.gov) | July 1998 | 14/9/2005 | T-Cell Vaccination in Multiple Sclerosis (MS) | The Effect of T-Cell Vaccination in Multiple Sclerosis - Phase I/II Safety and Efficacy Trial | Multiple Sclerosis | Biological: T-Cell Vaccination | Sheba Medical Center | NULL | Recruiting | 16 Years | 60 Years | Both | 20 | Phase 1/Phase 2 | Israel |